The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these studies. There are some that feel that only a randomized clinical trial can produce robust study results that are scientifically sound and provide relevant data for sponsors and regulatory authorities. Within this podcast we will explore the scientific integrity of post-marketing and observational research, and how these studies can provide important information that can complement your early phase clinical trial results.
21st Century Cures Act and Real-World Evidence
Is Marijuana a Replacement for Opioids?
PRA INSIGHTS REPORT 2018 ISPOR-North America Survey Results
A summary of survey results from ISPOR’s Annual North America meeting, where we gathered insights on important developments in the real world…